Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:918-922

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Svetkey, L. P.
Right arrow Articles by Wilson, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Svetkey, L. P.
Right arrow Articles by Wilson, A. F.

(Hypertension. 1997;29:918-922.)
© 1997 American Heart Association, Inc.


Articles

Preliminary Evidence of Linkage of Salt Sensitivity in Black Americans at the ß2-Adrenergic Receptor Locus

Laura P. Svetkey; Yuan-Tsong Chen; Sean P. McKeown; Lisa Preis; ; Alexander F. Wilson

From Duke University Medical Center, Durham, NC (L.P.S., Y.-T.C., L.P.); Louisiana State University Medical Center (S.P.M.), New Orleans; and National Institutes of Health, National Center for Human Genome Research, Baltimore, Md (A.F.W.).


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract Salt sensitivity is a heritable trait that is a hallmark of hypertension in black Americans. Genes encoding adrenergic receptors are candidate loci for the inheritance of this hypertension-related trait because of the role of these receptors in the regulation of renal sodium excretion and vascular tone. We performed this study to determine whether these loci are responsible for some of the phenotypic variation in salt sensitivity. Hypertensive black American probands were ascertained, followed by sequential ascertainment of adult sib pairs among the first-, second- and third-degree relatives of the proband. Both hypertensive and normotensive siblings were tested for salt sensitivity by an intravenous sodium-loading, lasix volume-depletion protocol. Genotyping was performed with restriction fragment length polymorphisms in genomic DNA probed with clones containing the ß2- and {alpha}2c10-adrenergic receptor genes. A total of 109 sib pairs was evaluated. Salt sensitivity was defined as the change in blood pressure in each individual, comparing the sodium-loaded with the volume-depleted state. Systolic pressure decreased by an average of 9.0±9%, diastolic pressure by 1.5±11%, and mean arterial pressure by 5.0±9%. Neither blood pressure nor salt sensitivity was linked at the {alpha}2c10-adrenergic receptor locus. No evidence suggested that systolic salt sensitivity and baseline blood pressure were linked at the ß2-adrenergic receptor locus. Model-independent sib pair linkage analysis suggested that diastolic blood pressure response to sodium loading/volume depletion is linked at the ß2-adrenergic receptor locus (P<.006). Evidence for linkage was significant at the .05 level after adjustment for the number of phenotypic traits examined.


Key Words: blacks • hypertension, genetic • genetics • sodium


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Salt sensitivity is defined as a change in blood pressure (BP) in response to changes in salt and water homeostasis. It is taken to be a hallmark of hypertension in blacks, found in 73% with high BP.1 Salt sensitivity may define a relatively homogeneous subgroup in whom hypertension develops through a common pathophysiological pathway. Thus, understanding the mechanisms of salt sensitivity may enhance our understanding of the pathophysiology of essential hypertension in black men and women.

Salt sensitivity, like hypertension, has a relatively high heritable component and can be treated as a qualitative or quantitative trait.2 3 4 5 A number of regulatory mechanisms could potentially lead to salt sensitivity, such as sodium excretion, vascular reactivity, or both. Genes that influence these phenomena can be considered to be candidate genes for salt sensitivity. Genes encoding two adrenergic receptors (ADRs) were investigated. The ß2-ADR gene, found on chromosome 5q31-32, regulates vascular smooth muscle relaxation. The {alpha}2-ADR genes are involved in the regulation of vascular smooth muscle contraction, sodium excretion, and renin release. The {alpha}2-ADR gene we investigated is located on chromosome 10q24-26 ({alpha}2c10). In this study, we used model-independent sib pair methods to test for linkage of the salt sensitivity phenotype in blacks with genotype at the ß2- and {alpha}2c10-ADR loci.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
This protocol was approved by the Duke University Medical Center Committee for Clinical Investigations (Institutional Review Board), and all subjects signed informed consent.

Ascertainment and Eligibility
Black families were ascertained through a single proband with hypertension, followed by sequential ascertainment of all available adult siblings (with or without hypertension) among the first-, second-, and third-degree relatives of the proband. We phenotyped and genotyped all sib pairs and genotyped all available parents of the sib pairs.

Subjects were excluded from the study if they were less than 18 years of age. In addition, subjects were excluded if they had a history of malignant or accelerated hypertension, if their diastolic BP was greater than 120 mm Hg, if there was a contraindication to discontinuing BP medications, or if they had a history of furosemide allergy. Subjects were also excluded if they showed evidence of impaired renal function (ie, serum creatinine >1.5 mg/dL [133 µmol/L], urinary protein excretion >500 mg/d, or active urinary sediment). Other exclusion criteria were myocardial infarction, cerebrovascular accident, or transient ischemic attack within the previous 6 months; congestive heart failure by history, physical examination, or chest radiograph; volume depletion; severe peripheral vascular disease; or inability to give informed consent or comply with the study protocol.

To confirm that reported parent-offspring relationships were biological, we typed parents and offspring with a battery of red blood cell markers and antigens designed to detect at least 70% of mistaken parentage.6 7 Subjects in whom biological parentage could not be confirmed were excluded from the analysis.

Data collected included demographic characteristics, anthropometric measurements, and plasma renin activity by radioimmunoassay. Dietary intake of sodium and potassium was estimated from 24-hour urinary excretion rates.

We performed salt sensitivity phenotyping at the Duke Clinical Research Unit using the intravenous sodium-loading/furosemide volume-depletion protocol of Grim et al.4 BP medication was tapered and discontinued at least 2 weeks before this evaluation.

Sodium Chloride Loading
After baseline BP measurements, normal saline (0.9%) was infused via the brachial vein at a rate of 2 L over 4 hours (8 AM to noon). The total sodium intake during this 24-hour period (intravenous plus dietary) was approximately 500 mEq (11 500 mg). Dietary potassium intake was 70 mEq/d (2730 mg/d).

Volume Depletion
Starting at 8 AM on the day after sodium loading, dietary sodium intake was limited to 10 mEq (230 mg). Dietary potassium remained at 70 mEq (2730 mg/d), and subjects were allowed no more than 25 mL water/kg. Body weight, height, and skinfold thickness were used for estimation of lean body weight. Furosemide was then administered at a dose of 1 mg/kg lean body wt (maximum, 120 mg), divided into three oral doses over the day. This dose differs slightly from the original protocol of Grim et al,4 which used 120 mg lasix in all subjects. This modification was made for safety purposes and to normalize the diuresis so that it was equivalent to 120 mg furosemide in a 70-kg individual. Each subject was weighed before the second furosemide dose. If weight loss due to diuresis exceeded 3% of baseline (total) body weight, the third furosemide dose was reduced to avoid symptomatic hypotension.

BP Measurements
BP was measured by trained and certified personnel8 before the onset of saline infusion (baseline), at the end of saline infusion (sodium-loaded), and 24 hours after the first furosemide dose (volume-depleted). Each BP measurement consisted of the average of two seated measurements made with a mercury sphygmomanometer using the same arm and an appropriately sized cuff. Subjects were seated for at least 5 minutes before each BP recording. In addition, for safety purposes, BP was measured every hour throughout the saline-loading and volume-depletion procedures.

The sodium-loading procedure was terminated before completion if systolic BP exceeded 180 mm Hg, if diastolic BP exceeded 120 mm Hg, or if symptoms related to elevated BP or volume expansion developed. The volume-depletion procedure was terminated before completion if the subject developed symptomatic hypotension. If the procedure was terminated before completion, the last BP before termination was used in the salt sensitivity calculations. One individual prematurely terminated the salt sensitivity procedure.

Interpretation
Baseline BP was defined as the average of the two seated measurements taken just before the onset of sodium infusion. As previously reported by Grim et al,4 salt sensitivity was defined as the continuous variables representing the decrease in systolic, diastolic, and mean arterial pressures going from the sodium-loaded to the volume-depleted state. The decrease in pressure was expressed as a percentage of the sodium-loaded pressure; similar salt sensitivity results were obtained when absolute values were used. Salt sensitivity was calculated from the formula [(BPsodium loaded-BPvolume depleted)/BPsodium loaded]x100. Mean arterial pressure was calculated from the formula [(2xDiastolic BP)+Systolic BP]/3.

Genetic Analysis
Genomic DNA was extracted from leukocytes in whole blood and digested with restriction enzymes that had been previously reported to reveal polymorphisms of the ß2- and {alpha}2c10-ADR genes.9 10 Probes for the full-length coding sequences were provided by Dr Robert Lefkowitz (Duke University Medical Center). Restriction fragment length polymorphisms were identified by Southern blot. Genotyping methods are described elsewhere.11

Statistical Analysis
We used the Haseman-Elston sib-pair test to perform linkage analysis as implemented in SIBPAL (SAGE, 1994).12 In the Haseman-Elston test, information from both the siblings' and their parents' marker genotypes is used to estimate, with Bayesian methods, the proportion of alleles each sib pair shares identical-by-descent (IBD) at the marker locus. In the case of the candidate gene approach, the candidate gene is itself the marker locus. For quantitative traits, the squared sib pair trait difference, in this case the difference in the degree of salt sensitivity, is regressed on the estimated proportion of alleles each sib pair shares IBD at the candidate/marker locus or a locus tightly linked to it. If the candidate locus is responsible for at least some of the variation in the degree of salt sensitivity, siblings with an estimated proportion of alleles IBD that is high (ie, they are more likely to be concordant at the candidate/marker locus) should also be similar phenotypically (ie, they should have a similar degree of salt sensitivity and thus a small squared sib pair trait difference). In this case, the slope of the regression line will be negative. On the other hand, if the candidate/marker locus or a locus tightly linked to it is not involved in the variation of salt sensitivity, there will be no change in salt sensitivity with respect to the estimated proportion of alleles IBD, and the slope of the regression will be zero. The P value indicates the probability that the observed (or a greater) slope would occur if the "true" slope were zero.

In the present study, we used parental genotype data to estimate the proportion of alleles IBD when these data were available and informative. When parental genotyping was not available, we used population gene frequencies obtained from 96 unrelated black Americans who had been previously genotyped at the ß2- and {alpha}2c10-ADR loci.2

The inclusion of covariate information may be critical in identifying genetic components, especially if the covariate has a substantial effect on the phenotype. We used Pearson product-moment correlation coefficients to test for relationships between salt sensitivity and BP-related variables such as age, body composition, and plasma renin activity. Variables significantly correlated with salt sensitivity were included in an adjusted sib-pair analysis.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Twenty black families were enrolled in the study. Genotype and phenotype data were available for 109 sib pairs within these families. The number of sib pairs in a sibship is represented by the formula s(s-1)/2, where s is the number of siblings in the sibship. Sibships ranged in size from two (with each sibship contributing 1 sib pair) to seven (with each sibship contributing 21 sib pairs).

Baseline characteristics of participating siblings are presented in Table 1Down. The mean age was 37 years (range, 19 to 58), 70% of participants were female, and 33% had hypertension.


View this table:
[in this window]
[in a new window]
 
Table 1. Baseline Characteristics of Study Subjects

Systolic, diastolic, and mean arterial BPs at baseline (ie, before saline infusion) are presented in Table 2Down. As noted above, our definition of salt sensitivity was the decrease in BP going from the saline-loaded state (ie, at the end of the saline infusion) to the volume-depleted state (ie, 24 hours after the first furosemide dose). Table 2Down indicates that systolic pressure decreased by an average of 9.0±9%, diastolic pressure by 1.5±11%, and mean arterial pressure by 5.0±9%. Thirty-three percent of participants had at least a 10% decrease in mean arterial pressure and therefore would be classified as salt sensitive.1


View this table:
[in this window]
[in a new window]
 
Table 2. Baseline Blood Pressure and Salt Sensitivity

There was no significant correlation between salt sensitivity and baseline BP, weight, body mass index, urinary sodium excretion, or urinary potassium excretion. The effect of the disproportionate enrollment of women in this study was presumably minimal because salt sensitivity and sex were not significantly correlated. As previously demonstrated,13 salt sensitivity was significantly correlated with age (r=.33, P=.0005); therefore, linkage analyses were performed with and without age adjustment. Results with and without this adjustment were essentially identical.

Table 3Down shows the results of the age-adjusted sib-pair linkage analysis. There was no evidence of linkage between any trait and the {alpha}2c10-ADR locus. At the ß2-ADR locus, there was no evidence of linkage with baseline pressure or systolic salt sensitivity. In contrast, the linkage analysis suggests that diastolic pressure response to the sodium-loading/volume-depletion maneuver was linked at the ß2-ADR locus (P<.006). Evidence for linkage was significant at the .05 level after adjustment for the number of traits examined (ie, baseline mean arterial pressure and systolic, diastolic, and mean arterial salt sensitivity).


View this table:
[in this window]
[in a new window]
 
Table 3. Age-Adjusted Sib-Pair Linkage Analysis


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The development of hypertension involves the complex interaction of several environmental and genetic influences, making the search for hypertension genes difficult. This search can be facilitated by the investigation of hypertension-related phenotypes that may lead to the identification of a population that is relatively homogeneous genetically and pathophysiologically.14 One hypertension-related phenotype of interest is the degree to which BP changes in response to changes in salt and water homeostasis. This salt sensitivity phenotype is measured as a relatively acute phenomenon but is presumed to represent a sustained response to chronic sodium intake. Indeed, BP changes in response to the saline/lasix protocol predict long-term changes in BP.13 Many investigators hypothesize that salt sensitivity reflects an underlying genetic predisposition to hypertension, particularly among blacks, in whom salt sensitivity is particularly prevalent.1 We investigated the genetic basis of the salt sensitivity phenotype in black sib pairs.

The heritability estimates of salt sensitivity, ie, the proportion of the phenotypic variance that can be attributed to additive genetic effects, ranges from .34 to as high as .84 in whites3 and blacks2 (and C.E. Grim, personal communication), similar to the heritability of BP itself.15 16

The mechanism by which salt sensitivity might lead to sustained BP elevation is unclear despite abundant data implicating salt intake in the development of hypertension. Salt sensitivity is attributed to a renal defect in sodium excretion, but salt-sensitive individuals do not continuously expand their intravascular volume. Therefore, several hypotheses have attempted to explain the connection between salt sensitivity and the hallmark of essential hypertension, increased peripheral vascular resistance. One tenable hypothesis is that salt sensitivity represents an altered responsiveness of both the kidneys and vasculature to circulating or local factors that regulate sodium excretion and vascular tone.17 Such altered responsiveness has been demonstrated in experimental18 and human19 20 21 22 23 salt sensitivity. The importance of the ADRs in vascular reactivity and renal sodium excretion provided the rationale for our investigation of the ß2- and {alpha}2c10-ADRs as candidate genes. Preliminary evidence of linkage at the ß2-ADR locus was observed.

ß2-ADRs are implicated in hypertension and salt sensitivity in studies suggesting deficient ß-mediated vasorelaxation.24 For instance, salt loading in salt-sensitive men is associated with increased vascular resistance25 26 27 and failure to decrease vasoconstrictor responses to angiotensin II.22 Two additional human studies suggest increased ß2-ADR sensitivity and density in blacks with hypertension28 and in individuals who show a pressor response to sodium loading.29 These findings may help explain the clinical observation that ß-blockers are less effective in lowering BP in blacks than in whites, but they are seemingly inconsistent with a hypothesis suggesting impaired ß-mediated vasodilation. However, in these studies, receptor density and function were evaluated in lymphocytes28 and skin fibroblasts,29 which may or may not reflect conditions in tissues involved in BP regulation. Although we have not evaluated receptor density, sensitivity, or function in our subjects, our observations are consistent with our previous findings of an association between genotype at this locus and the presence or absence of hypertension in unrelated blacks.11 Should evidence of linkage at this locus be confirmed by subsequent human studies, the functional correlates will need further exploration.

Although our sample size is small, these data suggest that the diastolic response to sodium loading and volume depletion is linked to the ß2-ADR locus. On average, diastolic BP changed little in response to the salt sensitivity maneuver (mean 1.5% decline), perhaps suggesting that the observed linkage is not clinically significant. However, the diastolic BP response ranged from a decrease of 24% to an increase of 20%, suggesting the possibility of heterogeneity of this response and thus the possibility of genetic heterogeneity. The lack of linkage of the systolic response may be consistent with data suggesting that systolic and diastolic BPs are under independent genetic influences.30

An alternative interpretation of our data is that the ß2-ADR locus is simply a marker for a salt sensitivity gene in that general region of chromosome 5 but does not itself play a role in the variation of salt sensitivity. A role for the ß2-ADR locus in the expression of salt sensitivity will require replication and subsequent confirmation of linkage with additional markers in that chromosomal region. Ultimately, the identification of variants at that locus that lead to altered receptor function will be necessary to confirm (or refute) the role of the ß2-ADR locus.

We noted no linkage of salt sensitivity at the {alpha}2c10-ADR locus. This is somewhat surprising in light of the location and function of these receptors. {alpha}2-Receptors are located on vascular smooth muscle cells and various cell types in the kidney and are known to influence vascular tone (both systemic and renal), proximal tubular sodium reabsorption, and renin release.31 However, several studies have failed to demonstrate an association of the {alpha}2c10-ADR with hypertension,32 33 although one report demonstrates an association in blacks.34 In previous work, we noted an association of {alpha}2c10 with hypertension in whites only and not in blacks.11 Thus, the role of the {alpha}2c10-ADR locus in salt sensitivity and hypertension remains unclear.

We designed this study to test a specific hypothesis concerning two ADR loci, requiring a focused and narrow approach to genotyping. A broader strategy for discovering salt sensitivity and hypertension genes, currently in progress in our laboratory, involves genomic screening. In this approach, polymorphic markers spanning the entire human genome are used to identify regions of linkage between hypertension and salt sensitivity traits and markers distributed throughout the human genome. Both approaches can be used to dissect out the genetic components underlying salt sensitivity and hypertension. The current use of the candidate gene approach provides preliminary evidence of linkage of diastolic salt sensitivity at the ß2-ADR locus.


*    Acknowledgments
 
This research was supported by Grant-in-Aid No. 92012180 from the American Heart Association and by grant RO1-HL-50176 from the National Institutes of Health (NIH). Additional support was provided by M01-RR-30, National Center for Research Resources, General Clinical Research Centers Program, NIH, and the National Center for Human Genome Research. The authors gratefully acknowledge the technical assistance of Kathryn Andersen.


*    Footnotes
 
Reprint requests to Laura P. Svetkey, MD, MHS, Box 3075, Duke University Medical Center, Durham, NC 27710.

Received October 4, 1996; first decision October 11, 1996; accepted October 11, 1996.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8(suppl II):II-127-II-134.

2. Svetkey LP, McKeown SP, Wilson AF. Heritability of salt sensitivity in black Americans. Hypertension. 1996;28:854-858. [Abstract/Free Full Text]

3. Miller JZ, Weinberger MH, Christian JC, Daugherty SA. Familial resemblance in the blood pressure response to sodium restriction. Am J Epidemiol. 1987;126:822-830. [Abstract/Free Full Text]

4. Grim CE, Miller JZ, Luft FC, Christian JC, Weinberger MH. Genetic influences on renin, aldosterone, and the renal excretion of sodium and potassium following volume expansion and contraction in normal man. Hypertension. 1979;1:583-590. [Abstract/Free Full Text]

5. Whitfield JB, Martin NG. Genetic and environmental causes of variation in renal tubular handling of sodium and potassium: a twin study. Gen Epidemiol. 1985;2:17-27.

6. Widmann F, ed. Technical Manual of the American Association of Blood Banks. 9th ed. Arlington, Va: American Association of Blood Banks; 1985: chaps 8-10.

7. Silver H, ed. Paternity Testing. Arlington, Va: American Association of Blood Banks; 1978: chap 3.

8. Sacks FM, Obarzanek E, Windhauser MM, Svetkey LP, Vollmer W, McCullough M, Karanja N, Lin P-H, Proschan MA, Appel LJ, Bray GA, Vogt TM, Moore TJ, for the DASH investigators. Rationale and design of the dietary approaches to stop hypertension trial (DASH): a multicenter controlled feeding study of dietary patterns associated with lower blood pressure. Ann Epidemiol. 1995;5:108-118. [Medline] [Order article via Infotrieve]

9. Lentes K-U, Berrettini WH, Hoehe MR, Chung F-Z, Gershon ES. A biallelic DNA polymorphism of the human beta2-adrenergic receptor detected by Ban I-Adrbr-2. Nucleic Acids Res. 1988;16:2359. [Free Full Text]

10. Hoehe MR, Berrettini WH, Lentes K-U. Dra I identifies a two allele DNA polymorphism in the human alpha2-adrenergic receptor gene (ADRAR), using a 5.5 kb probe (p ADRAR). Nucleic Acids Res. 1988;16:9070. [Free Full Text]

11. Svetkey LP, Timmons PZ, Emovon O, Anderson NB, Preis L, Chen Y-T. Association of hypertension with ß2- and {alpha}2c10-adrenergic receptor genotype. Hypertension. 1996;27:1210-1215. [Abstract/Free Full Text]

12. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus. Am J Hum Genet. 1993;52:506-516. [Medline] [Order article via Infotrieve]

13. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure: age and pressure change over time. Hypertension. 1991;18:67-71. [Abstract/Free Full Text]

14. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265:2037-2048. [Abstract/Free Full Text]

15. McIhany ML, Shaffer JW, Hines EA. The heritability of blood pressure: an investigation of 200 twin pairs using the cold pressure test. Johns Hopkins Med J. 1975;136:57-74. [Medline] [Order article via Infotrieve]

16. Feinleib M, Garrison RJ, Fabsitz R, Christian JC, Hrubec Z, Borhani NO, Kannel WB, Rosenman R, Schwartz JT, Wagner JO. The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results Am J Epidemiol. 1977;106:284-295. [Abstract/Free Full Text]

17. Aviv A, Aladjem M. Essential hypertension in blacks: epidemiology, characteristics, and possible roles of racial differences in sodium, potassium and calcium regulation. Cardiovasc Drugs Ther. 1990;4:335-342.

18. Rapp JP. Dahl salt-susceptible and salt-resistant rats: a review. Hypertension. 1982;4:753-763. [Free Full Text]

19. Mark AL, Lawton WJ, Abboud FM, Fitz AE, Connor WE, Heistad DD. Effects of high and low sodium intake on arterial pressure and forearm vascular resistance in borderline hypertension: a preliminary report. Circ Res. 1975;36(suppl I):I-195-I-198.

20. Sullivan JM, Prewitt RL, Ratts TE. Sodium sensitivity in normotensive and borderline hypertensive humans. Am J Med Sci. 1988;295:370-377. [Medline] [Order article via Infotrieve]

21. Koolen MI, Bussemaker-Verduyn den Boer E, van Brummelen P. Clinical, biochemical, and haemodynamic correlates of sodium sensitivity in essential hypertension. J Hypertens. 1983;1(suppl 2):21-23.

22. Egan BM, Petrin J, Hoffmann RG. NaCl induces differential changes of regional vascular reactivity in salt-sensitive versus salt-resistant men. Am J Hypertens. 1991;4:924-931. [Medline] [Order article via Infotrieve]

23. Campese VM, Romoff MS, Levitan J, Saglikes Y, Friedlier R, Massry SG. Abnormal relationship between sodium intake and plasma norepinephrine in patients with essential hypertension. Kidney Int. 1982;21:371-378. [Medline] [Order article via Infotrieve]

24. Feldman RD. Beta-adrenergic receptor alterations in hypertension: physiological and molecular correlates. Can J Physiol Pharmacol. 1987;65:1666-1672. [Medline] [Order article via Infotrieve]

25. Mark AL, Lawton WJ, Abboud FM, Fitz AE, Connor WE, Heistad DD. Effects of high and low sodium intake on arterial pressure and forearm vascular resistance in borderline hypertension. Circ Res. 1975;36-37(suppl I):I-194-I-198.

26. Takeshita A, Imaizumi T, Ashihara T, Nakamura M. Characteristics of responses to salt loading and deprivation in hypertensive subjects. Circ Res. 1982;51:457-464. [Free Full Text]

27. Sullivan JM, Ratts TE. Sodium sensitivity in human subjects: hemodynamic and hormonal correlates. Hypertension. 1988;11:717-723. [Abstract/Free Full Text]

28. Mills PJ, Dimsdale JE, Ziegler MG, Nelesen RA. Racial differences in epinephrine and beta2-adrenergic receptors. Hypertension. 1995;25:88-91. [Abstract/Free Full Text]

29. Kotanko P, Hoglinger O, Skrabal F. Beta2-adrenoceptor density in fibroblast culture correlates with human NaCl sensitivity. Am J Physiol. 1992;263:C623-C627. [Abstract/Free Full Text]

30. Avolio A. Genetic and environmental factors in the function and structure of the arterial wall. Hypertension. 1995;26:34-37. [Abstract/Free Full Text]

31. Jackson CA, Insel PA. Renal alpha-adrenergic receptors and genetic hypertension. Pediatr Nephrol. 1993;7:853-858. [Medline] [Order article via Infotrieve]

32. Sun L, Schulte N, Pettinger P, Regan JW, Pettinger JW. The frequency of alpha2-adrenoceptor restriction fragment length polymorphisms in normotensive and hypertensive humans. J Hypertens. 1992;10:1011-1015. [Medline] [Order article via Infotrieve]

33. Umemura S, Hirawa N, Iwamoto T, Yamaguchi S, Toya Y, Kobayashi S, Takasaki I, Yasudi G, Tamura K, Ishii M, Sun L, Pettinger W. Association analysis of restriction fragment length polymorphism for {alpha}2-adrenergic receptor genes in essential hypertension in Japan. Hypertension. 1994;23(suppl I):I-203-I-206.

34. Lockette W, Ghosh S, Farrow S, MacKenzie S, Baker S, Miles AS, Cadaret L. Alpha2-adrenergic receptor gene polymorphism and hypertension in blacks. Am J Hypertens. 1995;8:390-394.[Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
HypertensionHome page
B. C. Rossier and L. Schild
Epithelial Sodium Channel: Mendelian Versus Essential Hypertension
Hypertension, October 1, 2008; 52(4): 595 - 600.
[Full Text] [PDF]


Home page
HypertensionHome page
L. Pojoga, N. S. Kolatkar, J. S. Williams, T. S. Perlstein, X. Jeunemaitre, N. J. Brown, P. N. Hopkins, B. A. Raby, and G. H. Williams
{beta}-2 Adrenergic Receptor Diplotype Defines a Subset of Salt-Sensitive Hypertension
Hypertension, November 1, 2006; 48(5): 892 - 900.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. H. Eisenach, D. R. Schroeder, T. L. Pike, C. P. Johnson, W. G. Schrage, E. M. Snyder, B. D. Johnson, V. D. Garovic, S. T. Turner, and M. J. Joyner
Dietary sodium restriction and {beta}2-adrenergic receptor polymorphism modulate cardiovascular function in humans
J. Physiol., August 1, 2006; 574(3): 955 - 965.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J.-B. Choi, S. Hong, R. Nelesen, W. A. Bardwell, L. Natarajan, C. Schubert, and J. E. Dimsdale
Age and Ethnicity Differences in Short-Term Heart-Rate Variability
Psychosom Med, May 1, 2006; 68(3): 421 - 426.
[Abstract] [Full Text] [PDF]


Home page
West J Nurs ResHome page
R. M. Peters
Racism and Hypertension Among African Americans
West J Nurs Res, October 1, 2004; 26(6): 612 - 631.
[Abstract] [PDF]


Home page
HypertensionHome page
J. T. Wright Jr, M. Rahman, A. Scarpa, M. Fatholahi, V. Griffin, R. Jean-Baptiste, M. Islam, M. Eissa, S. White, and J. G. Douglas
Determinants of Salt Sensitivity in Black and White Normotensive and Hypertensive Women
Hypertension, December 1, 2003; 42(6): 1087 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. S. Zion, V. Bond, R. G. Adams, D. Williams, R. E. Fullilove, R. P. Sloan, M. N. Bartels, J. A. Downey, and R. E. De Meersman
Low arterial compliance in young African-American males
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H457 - H462.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Barlassina, C. Lanzani, P. Manunta, and G. Bianchi
Genetics of Essential Hypertension: From Families to Genes
J. Am. Soc. Nephrol., November 1, 2002; 13(90003): S155 - 164.
[Abstract] [Full Text]


Home page
HypertensionHome page
T. A. Kotchen, U. Broeckel, C. E. Grim, P. Hamet, H. Jacob, M. L. Kaldunski, J. M. Kotchen, N. J. Schork, P. J. Tonellato, and A. W. Cowley Jr
Identification of Hypertension-Related QTLs in African American Sib Pairs
Hypertension, November 1, 2002; 40(5): 634 - 639.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
F. C. Luft
Molecular Genetics of Salt-Sensitivity and Hypertension
Drug Metab. Dispos., April 1, 2001; 29(4): 500 - 504.
[Abstract] [Full Text]


Home page
HypertensionHome page
N. Kato, T. Sugiyama, H. Morita, H. Kurihara, T. Sato, Y. Yamori, and Y. Yazaki
Association Analysis of {beta}2-Adrenergic Receptor Polymorphisms With Hypertension in Japanese
Hypertension, February 1, 2001; 37(2): 286 - 292.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. Hamet, N. Thorin-Trescases, P. Moreau, P. Dumas, B.-S. Tea, D. deBlois, V. Kren, M. Pravenec, J. Kunes, Y. Sun, et al.
Workshop: Excess Growth and Apoptosis : Is Hypertension a Case of Accelerated Aging of Cardiovascular Cells?
Hypertension, February 1, 2001; 37(2): 760 - 766.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. M. Stein, C. C. Lang, I. Singh, H. B. He, and A. J. J. Wood
Increased Vascular Adrenergic Vasoconstriction and Decreased Vasodilation in Blacks : Additive Mechanisms Leading to Enhanced Vascular Reactivity
Hypertension, December 1, 2000; 36(6): 945 - 951.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. Levy, A. L. DeStefano, M. G. Larson, C. J. O'Donnell, R. P. Lifton, H. Gavras, L. A. Cupples, and R. H. Myers
Evidence for a Gene Influencing Blood Pressure on Chromosome 17 : Genome Scan Linkage Results for Longitudinal Blood Pressure Phenotypes in Subjects From the Framingham Heart Study
Hypertension, October 1, 2000; 36(4): 477 - 483.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. K. Agarwal, G. Giacchetti, G. Lavery, H. Nikkila, M. Palermo, M. Ricketts, C. McTernan, G. Bianchi, P. Manunta, P. Strazzullo, et al.
CA-Repeat Polymorphism in Intron 1 of HSD11B2 : Effects on Gene Expression and Salt Sensitivity
Hypertension, August 1, 2000; 36(2): 187 - 194.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. W. COWLEY JR., M. STOLL, A. S. GREENE, M. L. KALDUNSKI, R. J. ROMAN, P. J. TONELLATO, N. J. SCHORK, P. DUMAS, and H. J. JACOB
Genetically defined risk of salt sensitivity in an intercross of Brown Norway and Dahl S rats
Physiol Genomics, April 27, 2000; 2(3): 107 - 115.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Busjahn, G.-H. Li, H.-D. Faulhaber, M. Rosenthal, A. Becker, E. Jeschke, H. Schuster, B. Timmermann, M. R. Hoehe, and F. C. Luft
{beta}-2 Adrenergic Receptor Gene Variations, Blood Pressure, and Heart Size in Normal Twins
Hypertension, February 1, 2000; 35(2): 555 - 560.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Dzimiri
Regulation of beta -Adrenoceptor Signaling in Cardiac Function and Disease
Pharmacol. Rev., September 1, 1999; 51(3): 465 - 502.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Gratze, J. Fortin, R. Labugger, A. Binder, P. Kotanko, B. Timmermann, F. C Luft, M. R Hoehe, and F. Skrabal
ß-2 Adrenergic Receptor Variants Affect Resting Blood Pressure and Agonist-Induced Vasodilation in Young Adult Caucasians
Hypertension, June 1, 1999; 33(6): 1425 - 1430.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Takami, Z. Y. H. Wong, M. Stebbing, and S. B. Harrap
Linkage analysis of glucocorticoid and beta 2-adrenergic receptor genes with blood pressure and body mass index
Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1379 - H1384.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Svetkey, L. P.
Right arrow Articles by Wilson, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Svetkey, L. P.
Right arrow Articles by Wilson, A. F.